236 related articles for article (PubMed ID: 24047107)
1. Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?
Visco C; Cortelezzi A; Moretta F; Falisi E; Maura F; Finotto S; Barcellini W; Ambrosetti A; Neri A; Ruggeri M; Rodeghiero F
Leuk Lymphoma; 2014 Jun; 55(6):1261-5. PubMed ID: 24047107
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kyasa MJ; Parrish RS; Schichman SA; Zent CS
Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
[TBL] [Abstract][Full Text] [Related]
3. Secondary autoimmune cytopenias in chronic lymphocytic leukemia.
Rogers KA; Woyach JA
Semin Oncol; 2016 Apr; 43(2):300-10. PubMed ID: 27040709
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases.
Shvidel L; Tadmor T; Braester A; Bairey O; Rahimi-Levene N; Herishanu Y; Klepfish A; Shtalrid M; Berrebi A; Polliack A;
Ann Hematol; 2013 May; 92(5):661-7. PubMed ID: 23274356
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations.
De Back TR; Kater AP; Tonino SH
Expert Rev Hematol; 2018 Aug; 11(8):613-624. PubMed ID: 29923432
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune cytopenia in chronic lymphocytic leukemia: diagnosis and treatment.
Yevstakhevych YL; Vyhovska YI; Yevstakhevych IY; Vyhovska OY; Pelenyo NV; Semerak MM; Novak VL; Loginsky VE
Exp Oncol; 2020 Dec; 42(4):318-323. PubMed ID: 33355861
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma.
Zent CS; Ding W; Schwager SM; Reinalda MS; Hoyer JD; Jelinek DF; Tschumper RC; Bowen DA; Call TG; Shanafelt TD; Kay NE; Slager SL
Br J Haematol; 2008 May; 141(5):615-21. PubMed ID: 18373706
[TBL] [Abstract][Full Text] [Related]
8. Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans.
Xia Y; Fan L; Wang L; Gale RP; Wang M; Tian T; Wu W; Yu L; Chen YY; Xu W; Li JY
Oncotarget; 2015 Mar; 6(7):5426-34. PubMed ID: 25605254
[TBL] [Abstract][Full Text] [Related]
9. Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome.
Carli G; Visco C; Falisi E; Perbellini O; Novella E; Giaretta I; Ferrarini I; Sandini A; Alghisi A; Ambrosetti A; Rodeghiero F
Ann Hematol; 2016 May; 95(6):863-70. PubMed ID: 27001309
[TBL] [Abstract][Full Text] [Related]
10. A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.
Tsang M; Parikh SA
Curr Hematol Malig Rep; 2017 Feb; 12(1):29-38. PubMed ID: 28197963
[TBL] [Abstract][Full Text] [Related]
11. Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia.
Le Bris Y; Struski S; Guièze R; Rouvellat C; Prade N; Troussard X; Tournilhac O; Béné MC; Delabesse E; Ysebaert L
Hematol Oncol; 2017 Dec; 35(4):664-670. PubMed ID: 27678008
[TBL] [Abstract][Full Text] [Related]
12. LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.
Kristensen L; Kristensen T; Abildgaard N; Royo C; Frederiksen M; Mourits-Andersen T; Campo E; Møller MB
Eur J Haematol; 2016 Aug; 97(2):175-82. PubMed ID: 26558352
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance.
Moreno C; Hodgson K; Ferrer G; Elena M; Filella X; Pereira A; Baumann T; Montserrat E
Blood; 2010 Dec; 116(23):4771-6. PubMed ID: 20736453
[TBL] [Abstract][Full Text] [Related]
14. Watch and Wait in Lebanese Chronic Lymphocytic Leukemia Patients: How Relevant is it?
Lutfallah AA; Kourie HR; Eid R; Farhat F; Ghosn M; Kattan J
Asian Pac J Cancer Prev; 2016; 17(1):215-7. PubMed ID: 26838212
[TBL] [Abstract][Full Text] [Related]
15. ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients.
Zanotti R; Frattini F; Ghia P; Visco C; Zamò A; Perbellini O; Stella S; Facco M; Giaretta I; Chilosi M; Pizzolo G; Ambrosetti A
Am J Hematol; 2010 Jul; 85(7):494-8. PubMed ID: 20575031
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and prognostic significance of autoimmune cytopenias in a cohort of Egyptian patients with chronic lymphocytic leukemia.
Atef B; Azmy E; Aladle D; Mabed M
Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):97-104. PubMed ID: 30802421
[TBL] [Abstract][Full Text] [Related]
17. CD11c expression in chronic lymphocytic leukemia revisited, related with complications and survival.
Umit EG; Baysal M; Durmus Y; Demir AM
Int J Lab Hematol; 2017 Oct; 39(5):552-556. PubMed ID: 28603911
[TBL] [Abstract][Full Text] [Related]
18. Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
Michallet AS; Rossignol J; Cazin B; Ysebaert L
Leuk Lymphoma; 2011 Jul; 52(7):1401-3. PubMed ID: 21699387
[TBL] [Abstract][Full Text] [Related]
19. [Chronic lymphocytic leukemia].
Maurer C; Hallek M
Dtsch Med Wochenschr; 2013 Oct; 138(42):2153-66. PubMed ID: 24104591
[TBL] [Abstract][Full Text] [Related]
20. Clinical and serological autoimmune complications in chronic lymphocytic leukemia.
Demir C; Ekinci Ö
Wien Klin Wochenschr; 2017 Aug; 129(15-16):552-557. PubMed ID: 28477093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
